FdaApplication
BLA 125700
Identifiers
- fda_app_no: BLA125700
Properties
| Property | Value |
|---|---|
| applicant_name | Ferring Pharmaceuticals A/S |
| application_type | BLA |
| approval_date | 2022-12-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ADSTILADRIN | — | 3x10^11 viral particles (vp)/mL | For Suspension |
1 product